You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pediatrics, Homozygous Familial Hypercholesterolemia, Alirocumab, PCSK9 inhibitor, Low-density Lipoprotein Cholesterol (LDL-C)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Familial Trial (Evolocumab, Placebo)

Completed
Has Results
  • Hypercholesterolemia, Familial
  • Evolocumab
  • Placebo
  • (no location specified)
Jan 4, 2021

Familial Hypercholesterolaemia Trial in Czechia (Total cholesterol (TC) level test and direct Low density lipoprotein

Recruiting
  • Familial Hypercholesterolaemia
  • Total cholesterol (TC) level test and direct Low density lipoprotein cholesterol (LDL-C) level test
  • DNA testing
  • Brno, Czechia
  • +10 more
Nov 25, 2022

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)

Completed
Has Results
  • Familial Hypercholesterolemia
  • Evolocumab
  • Bronx, New York
  • +45 more
Dec 16, 2021

Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Wilmington, Delaware
  • +10 more
Jan 30, 2023

Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)

Recruiting
  • Familial Hypercholesterolemia - Heterozygous
  • Tucson, Arizona
  • +76 more
Aug 8, 2022

Hypercholesterolemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Atorvastatin, Simvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab SAR236553 (REGN727)
  • +11 more
  • Sao Paulo, Brazil
  • +9 more
Dec 2, 2020

Hypercholesterolemia, Familial Hypercholesterolemia Trial in Worldwide (MK-0616, Placebo)

Active, not recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • Beverly Hills, California
  • +62 more
Aug 2, 2022

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other

Not yet recruiting
  • To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
  • Combination for Subgroup High LDL-c Patients With Other Comorbidities
  • RN0191 INJECTION
  • (no location specified)
Jun 14, 2023

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • ALIROCUMAB SAR236553 (REGN727)
  • +5 more
  • Graz, Austria
  • +152 more
Mar 21, 2022

Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • IBI306
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 12, 2022

Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

Not yet recruiting
  • Primary Hypercholesterolemia or Mixed Dyslipidemia
  • (no location specified)
May 24, 2023

Hypercholesterolaemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin)

Active, not recruiting
  • Hypercholesterolaemia
  • Alirocumab SAR236553 (REGN727)
  • +12 more
  • Boca Raton, Florida
  • +45 more
Jan 12, 2022

Qualitative Features of Atherosclerotic Plaques

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • Riga, Latvia
    Pauls Stradins Clinical University Hospital
Dec 5, 2022

Homozygous Familial Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo)

Completed
Has Results
  • Homozygous Familial Hypercholesterolemia
  • Boca Raton, Florida
  • +27 more
Jun 7, 2021

Hypercholesterolemia Trial in Beijing (IBI306 450mg SC Q4W, Placebo SC Q4W, IBI306 600mg SC Q6W)

Completed
  • Hypercholesterolemia
  • IBI306 450mg SC Q4W
  • +3 more
  • Beijing, China
    Peking University First Hospital
Apr 2, 2022

Familial Hypercholesterolemia Trial (phytosterol, krill oil, Placebo phytosterol)

Not yet recruiting
  • Familial Hypercholesterolemia
  • phytosterol
  • +3 more
  • (no location specified)
Jan 13, 2023

Cognitive Function in Patients Treated With PCSK9 Inhibitors

Completed
  • Cognitive Function
  • +2 more
  • PCSK9 inhibitor
  • Cee, A Coruña, Spain
  • +11 more
Jan 13, 2023

Familial Hypercholesterolemia, Atherosclerosis Trial (Visualization of coronary Imaging and oral description)

Not yet recruiting
  • Familial Hypercholesterolemia
  • Atherosclerosis
  • Visualization of coronary Imaging and oral description
  • (no location specified)
Mar 6, 2023

Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

Not yet recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Bempedoic acid and/or its fixed dose combination with ezetimibe
  • (no location specified)
Mar 23, 2023

Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +6 more
  • Birmingham, Alabama
  • +243 more
Nov 4, 2022

Patients With High Cholesterol and Normal Volunteers

Completed
  • Homozygous Familial Hypercholesterolemic
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 12, 2023